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osting by EAbstract Composite graft replacement of the aortic root and coronary reimplantation with or
without coronary artery bypass surgery is the standard treatment for a variety of aortic root pathol-
ogies. Previously, percutaneous coronary intervention of either reimplanted coronary arteries or
left/right coronary artery through cabrol graft has been described in post-Bentall patients. We
describe percutaneous coronary intervention of a saphenous vein graft ostial stenosis in a patient
with previous Bentall procedure and a vein graft to right coronary artery, which was complex
and challenging.
ª 2010 King Saud University. All rights reserved.1. Case report
A 59-year-old male hypertensive presented with three months
history of exertional angina class II. He had undergone a Ben-
tall procedure in 2001 in UK for aortic aneurysm and severe
aortic regurgitation. His coronary angiogram at that time had
revealed normal left system but signiﬁcant right coronary ar-
tery (RCA) disease. The right and left main coronary ostia were
then reimplanted onto the sides of aortic tube graft and he hadartment of Cardiology, Royal
Oman. Tel.: +968 92603746;
co.in (P. Panduranga).
ity. All rights reserved. Peer-
d University.
lseviera saphenous vein graft (SVG) to distal RCA with proximal
implantation in the composite graft. His clinical examination
was normal with well heard prosthetic clicks. His electrocardio-
gram showed left ventricular hypertrophy with no ischemic
changes and an echocardiogram done revealed normally func-
tioning single disc mechanical prosthetic valve with no leaks,
mild concentric left ventricular hypertrophy, no resting regio-
nal wall motion abnormalities, and an estimated ejection frac-
tion of 60%. He underwent stress myocardial perfusion scan
which revealed reversible perfusion defects in mid inferior
and mid infero-lateral segments. His medications included aspi-
rin, isosorbide dinitrate, atenolol, amlodepine and warfarin. He
was given loading dose of clopidogrel 300 mg and underwent
percutaneous coronary intervention (PCI).
A standard Judkins right (JR) diagnostic catheter managed
to cannulate the right coronary, which showed multiple tight
90% lesions in proximal and mid RCA. The left system was
cannulated with Judkins left diagnostic catheter and was nor-
mal. It was not able to cannulate the SVG graft with diagnostic
JR4, multipurpose (MPA), Amplatz right or right coronary
bypass (RCB) catheters. An ascending aortogram done
216 M. Mukhaini, P. Pandurangashowed tight 95% ostial stenosis of SVG to RCA with no sig-
niﬁcant disease distally. During intervention various guide
catheters were used unsuccessfully to cannulate SVG including
JR, RCB, MPA, Amplatz right/left, and MRESS radial cath-
eters. Once again, a 6F RCB guiding catheter was tried and
successfully engaged the SVG graft and the angiogram con-
ﬁrmed tight focal nonthrombotic ostial lesion (Fig. 1A).
The ostial stenosis was crossed with a 0.014 inch PT Graph-
ix Standard wire (Boston Scientiﬁc Corp.) after repeated at-
tempts, and was passed into the distal RCA. As the
restenosis rate is high in older venous grafts as well as in those
involving aortic origin, and as it would be difﬁcult to cannulate
and cross SVG if repeat procedure is needed in future, it was
decided to deploy a drug-eluting stent (DES) after discussing
with the patient. The lesion was pre-dilated with 1.5 · 15 mm
then 2.5 · 15 mm balloons (Fig. 1B) followed by ostial deploy-
ment of 3.0 · 12 mm Taxus (Boston Scientiﬁc Corp.) at 14
atmospheres (Fig. 2A). This was followed by post dilatation
using 3 · 10 mm noncompliant balloon with ostial ﬂaring.
An optimal angiographic result was obtained with 0% stenosis
and TIMI 3 ﬂow distally (Fig. 2B). The patient tolerated the
procedure well and was discharged on dual antiplatelets along
with his other medications. Patient is doing well at one year
follow-up.2. Discussion
Since the original description of the Bentall–DeBono proce-
dure in 1968 (Bentall and De Bono, 1968), composite graft
replacement of the aortic root with coronary reimplantation
has become the standard treatment for a variety of aortic root
pathologies. Coronary artery bypass surgery (CABG) using
arterial or venous grafts is done in Bentall patients with either
signiﬁcant coronary artery disease or if coronaries are involved
in dissection. Previously, PCI of either reimplanted coronary
arteries (Worthley et al., 2005) or left/right coronary artery
through cabrol graft (Hussain et al., 2006) have been described
in patients with prior Bentall procedure. Given the few number
of patients who have undergone Bentall and coronary bypass
graft surgery with venous conduits and the well-documented
continuous rate of attrition in these grafts, treating post-Ben-Figure 1 (A) Saphenous venous graft injection in left anterior obliqu
Bentall procedure. (B) Predilatation of ostial vein graft stenosis.tall patients with saphenous vein graft stenosis is complex
and challenging.
Anastamotic complications of the coronary ostia after suc-
cessful Bentall-type surgery for aortic root replacement have
been reported, with an estimated incidence of 5–6% (Milano
et al., 2003). In a study by (Sako et al., 2003) 33 venous bypass
grafts were analyzed in 24 survivors of Bentall procedure. There
was one early SVG occlusion of 16 anastomosed to the left
anterior descending artery (LAD). All 14 venous grafts anasto-
mosed to the RCA and 3 to the left circumﬂex artery were
patent. Spiral computed tomography performed for long-term
follow-up revealed occlusion of two vein grafts (3.5 years and
9.7 years) anastomosed to the LAD. They concluded that the
patency rate of vein grafts anastomosed from prosthetic grafts
of the ascending aorta to the native coronary arteries was
similar to that of conventional CABG using SVGs.
Our patient developed ostial SVG stenosis 8 years after aor-
tic procedure and was treated successfully with percutaneous
intervention. For venous graft stenosis the underlying patho-
physiology is complex, with degenerated atheromatous lesions
and often superimposed thrombus. Stenosis results from inti-
mal hyperplasia, atherosclerotic plaque build-up, and graft
remodeling similar to that observed in native coronary arteries.
With the introduction of bare metal stents (BMS), PCI has be-
come a standard strategy for treatment of SVG failure. How-
ever, use of BMS is associated with restenosis rates as high as
50% at 6 months (De Jaegere et al., 1996). With the introduc-
tion of DES, it has been used ‘‘off-label’’ for the treatment of
SVG disease. The RRISC (Reduction of Restenosis in Saphe-
nous vein grafts with Cypher SES) trial (Vermeersch et al.,
2006) and the study by (Ge et al., 2005) showed signiﬁcant ben-
eﬁt of DES compared to BMS at 6 months of follow-up for
treatment of SVG disease. Recently, there has been much con-
troversy about the long-term safety of DES in SVG disease.
The publication of the secondary post hoc analysis results
from delayed RRISC trial (Vermeersch et al., 2007) showed
that over a follow-up of 32 months, use of BMS was associated
with lower long-term mortality than the use of DES in SVG
disease. Another study by Bansal et al. over a mean follow-
up of 33 months showed no difference in the long-term out-
comes of PCI on SVG irrespective of the type of stent used
(Bansal et al., 2008).e projection showing tight ostial stenosis in a patient with previous
Figure 2 (A) Stenting of ostial vein graft lesion. (B) Final angiogram following stenting of ostial vein graft stenosis in a patient with
previous Bentall procedure.
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problems. Speciﬁcally, coronary graft cannulation, catheter
backup support and ease of proper stent deployment. Chal-
lenge in this case was engaging the vein graft with appropriate
catheter. Repeated attempts at cannulation of the SVG ostium
with various guiding catheters are commonly required. Multi-
ple catheters were tried, but ﬁnally we could engage with RCB
guide with good backup support and this guide seems to be
ideal for RCA grafts in post-Bentall patients. As our patient
had predominantly focal stenosis with no signiﬁcant vein
degeneration we did not use distal protection device. Proper
stent apposition, expansion and coverage have to be done in
SVG ostial lesions and intravascular ultrasound may help in
these situations, but it is not available with us. However, our
ﬁnal result was excellent. To our knowledge, this is the ﬁrst
case of PCI in an ostial SVG graft after complete aortic root
replacement.
3. Conﬂict of interest
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